Anatolia Geneworks
Anatolia Geneworks is an Istanbul-based molecular diagnostics company that designs, manufactures, and distributes IVDR-certified Real-Time PCR kits (Bosphore) and automated nucleic acid extraction instruments (UNIO) to clinical laboratories, hospitals, and food safety testing facilities across 96 countries, publicly listed on Borsa Istanbul since 2021.
- Company typePublic
- Founded2010
- HeadquartersIstanbul
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Anatolia Geneworks does
Anatolia Geneworks is a molecular diagnostics company headquartered in Istanbul, Turkey, that designs, manufactures, and distributes Real-Time PCR kits and automated nucleic acid extraction instruments. The company was founded in 2010 by Alper Akyüz (President) and Elif Akyuz (Vice President) and has grown from a 5-person team in a 100 m² facility to approximately 220 employees across 15,000+ m² of R&D and production space, including a free-zone manufacturing site in Tuzla, Istanbul. Its product portfolio spans the Bosphore line of IVDR-certified Real-Time PCR kits covering over 100 parameters across microbiology, multiplex panels (STDs, sepsis, gastroenteritis, respiratory pathogens, hepatitis, HIV), genetic disorders, and food safety, alongside the proprietary UNIO family of automated extraction and sample-to-result instruments (UNIO A24S, B24, M32, 96-well, and the flagship UNIO 448 system). The company holds ISO 9001:2015, ISO 13485:2016, and EU IVD-CE certifications, was the first molecular diagnostics manufacturer in Turkey to receive IVDR certification (2024), and in 2026 obtained IVDR Class D certification — the highest-risk category under EU 2017/746 — for the Bosphore HBV Quantification Kit.
The business model combines one-time capital equipment sales (UNIO instruments) with recurring consumables revenue from PCR kits, extraction reagents, sample collection media, and rapid antigen tests sold to clinical laboratories, hospitals, food safety testing facilities, and genetic testing labs. Go-to-market is sales-led and event-driven: a dedicated B2B sales team is supplemented by participation at flagship industry congresses (ESCMID, MEDICA, KLİMUD, GfV), scientific workshops, and a distributor network reaching 96 countries with wholly-owned subsidiaries in Germany (RhineGene), Netherlands, Italy, Poland, Bulgaria, and Pakistan, plus Alpha-IVD and EuroNano Diagnostics as adjacent brands. Anatolia Geneworks has been publicly listed on Borsa Istanbul (BIST, ticker AG) since October 21, 2021, with share capital increased from 110,000,000 TL to 220,000,000 TL in March 2023. The company has no disclosed AI/ML product features, no disclosed revenue figures in the available source data, and operates with an 80% female Board composition and 96 women out of 238 professionals across the workforce.
Anatolia Geneworks firmographics
Firmographics- Name
- Anatolia Geneworks
- Legal name
- ANATOLIA TANI VE BIYOTEKNOLOJI URUNLERI AR-GE SAN. VE TIC. A.S.
- Website
- https://anatoliageneworks.com
- Company type
- Public
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Anatolia Geneworks is an Istanbul-based molecular diagnostics company that designs, manufactures, and distributes IVDR-certified Real-Time PCR kits (Bosphore) and automated nucleic acid extraction instruments (UNIO) to clinical laboratories, hospitals, and food safety testing facilities across 96 countries, publicly listed on Borsa Istanbul since 2021.
- Ownership category
- akta.pro rank
Anatolia Geneworks industry classification
Industry- Product category
- Molecular Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)
- akta.pro secondary industries
- Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA), Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF), Rapid On-Site Environmental Testing Kits & Instruments (Lateral Flow, PCR, ATP Devices) (AFALAEAK)
Keywords
Where Anatolia Geneworks is headquartered
LocationHeadquarters
- HQ city
- Istanbul
Offices8 records
Markets served
Anatolia Geneworks business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain
Revenue model
- Real-Time PCR Diagnostic Kits: Sale of Bosphore branded in vitro diagnostic Real-Time PCR reagent kits for detection of infectious diseases, genetic disorders, and food pathogens. Revenue is generated from consumable kit sales to clinical and research laboratories. Kits are sold in various configurations (singleplex and multiplex panels) with different package sizes. Turkish lira denominated sales through Istanbul Stock Exchange listed public company.
- Automated Instrumentation: Sale of UNIO branded automated nucleic acid extraction instruments and complete automation systems (UNIO 448). Instruments are sold as capital equipment to laboratories seeking integrated molecular diagnostic workflows. The UNIO 448 system represents the high-end fully automated sample-to-result platform.
- Nucleic Acid Extraction Reagents and Consumables: Supporting consumables including extraction kits, sample collection and transport media, and rapid antigen test kits. These provide recurring revenue from the installed instrument base.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels9 records
Anatolia Geneworks product offering
Product offeringCore offering
Anatolia Geneworks designs, develops, manufactures, and sells molecular diagnostic products — specifically Bosphore brand Real-Time PCR kits for infectious disease, genetic disorder, and food safety testing, along with UNIO brand automated nucleic acid extraction and PCR setup instruments. The products are sold to clinical laboratories, hospitals, and food testing facilities primarily through B2B direct sales and a 96-country international distributor network. The company is the first IVDR-certified molecular diagnostics manufacturer in Turkey and offers the first IVDR Class D certified Hepatitis B viral load quantification kit in the country.
Product overview
Anatolia Geneworks is a molecular diagnostics company offering a comprehensive portfolio of Real-Time PCR kits (Bosphore brand) and automated laboratory instruments (UNIO family). The product ecosystem centers on molecular diagnostic solutions for clinical microbiology, multiplex panels, genetic disorders, and food safety testing. Key product lines include: Bosphore Real-Time PCR Kits for detection of STDs, sepsis, gastroenteritis, hepatitis, respiratory pathogens, HIV, and other infectious diseases; UNIO automated instruments for nucleic acid extraction and full workflow automation including the UNIO 448 (sample-to-answer), UNIO A24S (extraction & PCR setup), and UNIO B24 (extraction); and rapid antigen tests. The company also offers IVDR-certified products and positions itself as a complete molecular diagnostic solutions provider.
Differentiator
Problem solved
Functional benefit
Brands
- Bosphore: Real-Time PCR kits brand for microbiology, multiplex panels, genetic disorders, and food testing applications
- UNIO
- Montania
- RhineGene
- Alpha IVD
- Euronano Diagnostics
Products and services
- UNIO 448 System Fully automated sample-to-answer system that integrates reagent preparation, nucleic acid extraction, and PCR into a single seamless workflow, offering high-throughput capacity of 448 tests in 8 hours with first results in approximately 113 minutes. Targets clinical laboratories and diagnostic facilities requiring high-volume automation.
- UNIO A24S Extraction & PCR Setup System that automates nucleic acid extraction and PCR preparation workflows for molecular diagnostic laboratories.
- UNIO B24 Extraction System for automated nucleic acid isolation using magnetic bead technology, for use in molecular diagnostic workflows.
- Bosphore STD Kits Comprehensive range of Real-Time PCR kits for detection of sexually transmitted disease pathogens including Chlamydia, Gonorrhea, Mycoplasma, Trichomonas, and other STD organisms. For use by clinical diagnostics laboratories and hospital molecular diagnostic departments.
- Bosphore Sepsis Kits Real-Time PCR kits for fast and accurate sepsis detection with option for screening antibiotic resistance genes simultaneously. For hospital and clinical laboratory sepsis diagnostics.
- Bosphore Gastroenteritis Kits Real-Time PCR panel kits enabling detection of 24 different bacterial, viral, and protozoan pathogens for gastroenteritis diagnosis. For clinical laboratories and hospital diagnostics.
- Bosphore Hepatitis Kits Real-Time PCR kits for detection, quantification and genotyping of Hepatitis viruses. For clinical laboratories performing hepatitis screening and viral load monitoring.
- Bosphore HIV-1 Kits Real-Time PCR kits for detection and quantification of HIV-1 RNA in human serum or plasma samples. For clinical virology laboratories performing HIV viral load testing.
- Bosphore Respiratory Pathogen Panel Kits Comprehensive range of multiplex Real-Time PCR kits for detection of respiratory pathogens including influenza, RSV, coronaviruses, and bacterial pneumonia organisms. For hospital and clinical respiratory diagnostics.
- Rapid Antigen Tests Point-of-care rapid antigen test kits for quick diagnostic results. For clinical point-of-care use and rapid screening settings.
- Sequencing Kits Kits for nucleic acid sequencing applications in molecular diagnostics and research use.
- Nucleic Acid Extraction Kits Reagent kits for manual and automated nucleic acid extraction to support the UNIO instrument family and broader molecular diagnostic workflows.
- Sample Collection & Transport Media Sample collection and transport media used to preserve clinical specimens for downstream molecular diagnostic testing. For clinical laboratory pre-analytical workflows.
Quantifiable outcome
- 448 tests processed in 8 hours with first results in approximately 113 minutes using UNIO 448 system
- +3 more outcomes
Companies that use Anatolia Geneworks
Customer profileSegments3 records
Ideal customer profiles3 records
Anatolia Geneworks technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Anatolia Geneworks partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- İdebil TeknolojicoreParent company and technology developer. Listed as the developer of the Anatolia Geneworks website and brand. İdebil Teknoloji appears to be the founding entity that established the Anatolia Geneworks brand and continues to support its digital and technology infrastructure.
- RhineGene GermanycoreSubsidiary company operating in Germany. Participated alongside Anatolia at the 35th GfV (Society of Virology) Annual Meeting in Heidelberg 2026. Serves as the company's European hub for distribution and brand presence.
- Alpha-IVDminorSubsidiary/distribution partner operating under the Alpha-IVD brand, shown as a partner logo on the Anatolia Geneworks homepage.
- EuroNano DiagnosticsminorDistribution partner operating under the EuroNano Diagnostics brand, shown as a partner logo on the Anatolia Geneworks homepage alongside Alpha-IVD and RhineGene.
- QMD ServicescoreEU Notified Body responsible for conducting IVDR audits and issuing IVDR certifications. Both initial IVDR certifications and new Class D certifications for Anatolia were granted following successful audits by QMD Services.
- TR.AQUA ConsortiumminorAnatolia is a founding/executive member of the TR.AQUA project focused on molecular diagnostics of waterborne pathogens. Hosted the Second Year Evaluation Meeting and participated in radio program 'Deep Blue Conversations' discussing molecular diagnostics of water pathogens.
Scale indicators12 records
Recent moves7 records
Expansion highlights5 records
Anatolia Geneworks competitors and assessment
Company assessmentBroad incumbents
- Cepheid (Danaher): Maker of GeneXpert/GeneXpert Xpress fully automated sample-to-result PCR systems — the gold-standard incumbent Anatolia's UNIO 448 is positioned against in high-throughput molecular diagnostics.
- Qiagen: Global molecular diagnostics leader with PCR reagent kits, automated extraction systems (QIAsymphony, QIAcube), and a broad sample-prep portfolio. Overlaps Anatolia in PCR kits and nucleic acid extraction but at vastly larger scale.
- bioMérieux: Major IVD player with strong clinical microbiology and molecular diagnostics (BioFire FilmArray, ARGENE). Competes with Anatolia in infectious disease PCR panels and food pathogen testing.
- Bio-Rad Laboratories: Established PCR technology provider (CFX real-time PCR systems, ddPCR) and IVD reagent manufacturer. Comparable to Anatolia's Real-Time PCR instruments (Montania) and Bosphore chemistry.
- Hologic: Molecular diagnostics incumbent behind the Panther automated system and a broad women's health / infectious disease assay menu. Direct overlap with Anatolia's STD, HPV, and infectious disease panels.
Emerging players
- ViennaLab Diagnostics: Austrian mid-sized IVD company focused on genetic testing and molecular diagnostics kits. Comparable European scale and product overlap with Anatolia, particularly in genetic disorders and infectious disease PCR.
- TIB Molbiol: German molecular diagnostics specialist (now part of Roche) with lightcycler-compatible Real-Time PCR kits for infectious disease and genetic testing. Comparable niche-PCR reagent focus to Anatolia's Bosphore line.
Direct peers
- ELITech Group: European molecular diagnostics company offering Real-Time PCR kits and automated extraction instruments across clinical microbiology and food safety — closely overlapping Anatolia's Bosphore kits and UNIO instruments portfolio.
- Seegene: Korean multiplex Real-Time PCR specialist with deep syndromic panel menus (respiratory, STI, gastro). Comparable to Anatolia in multiplex PCR chemistry and reagent-kit focus, though Seegene relies on partner-supplied instruments.
- R-Biopharm: German diagnostics company with Real-Time PCR kits for clinical and food-safety testing. Directly comparable to Anatolia in IVDR-certified PCR reagents and European food-pathogen detection.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Anatolia Geneworks social profiles
Digital presenceAnatolia Geneworks compliance and trust
Trust signalCompliance5 records
Anatolia Geneworks financial estimates
Financial estimateRevenue estimate
Valuation estimate
Anatolia Geneworks leadership team
Management profileNumber of profiles
Profiles2 records
Anatolia Geneworks subsidiaries and ownership
Company hierarchySubsidiaries3 records
Anatolia Geneworks funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Anatolia Geneworks M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Anatolia Geneworks
What does Anatolia Geneworks do?
Anatolia Geneworks designs, develops, manufactures, and sells molecular diagnostic products — specifically Bosphore brand Real-Time PCR kits for infectious disease, genetic disorder, and food safety testing, along with UNIO brand automated nucleic acid extraction and PCR setup instruments. The products are sold to clinical laboratories, hospitals, and food testing facilities primarily through B2B direct sales and a 96-country international distributor network. The company is the first IVDR-certified molecular diagnostics manufacturer in Turkey and offers the first IVDR Class D certified Hepatitis B viral load quantification kit in the country.
Is Anatolia Geneworks a public or private company?
Anatolia Geneworks is a public company. It is classified as public and is currently operating.
When was Anatolia Geneworks founded?
Anatolia Geneworks was founded in 2010. It employs 101 to 250 people.
Where is Anatolia Geneworks based?
Anatolia Geneworks is headquartered in Istanbul.
How does Anatolia Geneworks make money?
Three revenue lines are on record. Real-Time PCR Diagnostic Kits are the primary driver. The others are automated Instrumentation and nucleic Acid Extraction Reagents and Consumables.
Who are Anatolia Geneworks's main competitors?
Broad incumbents on record are Cepheid (Danaher), Qiagen, bioMérieux, Bio-Rad Laboratories and Hologic. Emerging players are ViennaLab Diagnostics and TIB Molbiol. Direct peers are ELITech Group, Seegene and R-Biopharm.
Does Anatolia Geneworks have an API?
No public API is recorded for Anatolia Geneworks.
What industry is Anatolia Geneworks in?
Anatolia Geneworks's product category is Molecular Diagnostics. Its primary akta.pro industry code is HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR), with a secondary code of HLAAALAA, Molecular Diagnostics (PCR/qPCR, NGS-based assays). Its NAICS code is 325413 and its SIC code is 2835.